Key facts
- Spryt’s last known valuation is $12.5M (Jan 2026).
- It has raised $290K; the latest was Accelerator/Incubator in Mar 2026.
- Notable investors include Innovate UK, Mayo Clinic Platform, Fountech Labs, Google Accelerator, MediDrive.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Spryt
- ·The full record, as it builds
Funding rounds
No funding rounds for Spryt are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Spryt
Developer of an intelligent appointment scheduling assistant designed to improve uptake and coverage rates for screening and immunization services. The company's software predicts and aims to prevent missed appointments, and to book or reschedule medical appointments via conversational message or voice, enabling users to maximize the time available for patient care while reducing operational inefficiencies in the system.
- Sector
- Healthcare
- HQ
- London, United Kingdom
- Founded
- 2017
- Employees
- 8
- Website
- spryt.com/
- Ownership
- Privately Held (backing)
Spryt doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Spryt shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Spryt in its N-PORT filings yet. We sweep new filings monthly.